STOCK TITAN

[Form 4] Plexus Corp Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Todd P. Kelsey, President & CEO and a director of Plexus Corp (PLXS), reported a sale of company stock under a pre-established 10b5-1 plan. On 09/02/2025 he disposed of 1,500 shares of Plexus common stock at $134.54 per share. After the reported sale, Mr. Kelsey beneficially owned 70,714 shares, held directly. The filing states the transactions were made pursuant to a Rule 10b5-1 plan adopted on August 16, 2024, and the Form 4 was signed on 09/03/2025 by an attorney-in-fact.

Todd P. Kelsey, Presidente e CEO nonché membro del consiglio di amministrazione di Plexus Corp (PLXS), ha comunicato la vendita di azioni della società effettuata nell'ambito di un piano 10b5-1 preesistente. Il 02/09/2025 ha ceduto 1.500 azioni ordinarie di Plexus al prezzo di $134,54 per azione. Dopo la vendita segnalata, il sig. Kelsey possedeva direttamente 70.714 azioni. La comunicazione indica che le operazioni sono state effettuate in base a un piano disciplinato dalla Rule 10b5-1 adottato il 16 agosto 2024, e il Modulo 4 è stato firmato il 03/09/2025 da un procuratore.

Todd P. Kelsey, presidente y CEO y miembro del directorio de Plexus Corp (PLXS), informó la venta de acciones de la compañía realizada bajo un plan 10b5-1 preestablecido. El 02/09/2025 dispuso la venta de 1.500 acciones ordinarias de Plexus a $134,54 por acción. Tras la operación notificada, el Sr. Kelsey poseía directamente 70.714 acciones. La presentación indica que las transacciones se efectuaron conforme a un plan Rule 10b5-1 adoptado el 16 de agosto de 2024, y el Formulario 4 fue firmado el 03/09/2025 por un apoderado.

플렉서스(Plexus Corp, PLXS)의 회장이자 CEO 겸 이사인 Todd P. Kelsey는 사전에 설정된 10b5-1 플랜에 따라 회사 주식을 매도했다고 보고했습니다. 2025년 9월 2일에 그는 보통주 1,500주를 주당 $134.54에 처분했습니다. 보고된 매도 후 Kelsey 씨는 직접 70,714주를 보유하고 있었습니다. 제출서류에는 거래가 2024년 8월 16일 채택된 Rule 10b5-1 플랜에 따라 이루어졌으며, Form 4는 2025년 9월 3일에 대리인이 서명했다고 명시되어 있습니다.

Todd P. Kelsey, président-directeur général et administrateur de Plexus Corp (PLXS), a déclaré la vente d'actions de la société réalisée dans le cadre d'un plan 10b5-1 préétabli. Le 02/09/2025, il a cédé 1 500 actions ordinaires de Plexus au prix de 134,54 $ par action. Après la vente déclarée, M. Kelsey possédait directement 70 714 actions. Le dépôt indique que les opérations ont été effectuées en vertu d'un plan Rule 10b5-1 adopté le 16 août 2024, et que le formulaire 4 a été signé le 03/09/2025 par un mandataire.

Todd P. Kelsey, Präsident & CEO sowie Direktor von Plexus Corp (PLXS), meldete den Verkauf von Unternehmensaktien im Rahmen eines vorab festgelegten 10b5-1-Plans. Am 02.09.2025 veräußerte er 1.500 Stammaktien von Plexus zum Preis von $134,54 je Aktie. Nach dem gemeldeten Verkauf hielt Herr Kelsey direkt 70.714 Aktien. Die Meldung besagt, dass die Transaktionen gemäß einem am 16. August 2024 angenommenen Rule‑10b5‑1‑Plan erfolgten und das Formular 4 am 03.09.2025 von einem Bevollmächtigten unterzeichnet wurde.

Positive
  • Transaction disclosed under a Rule 10b5-1 plan, which clarifies that the sale was preplanned and reduces concerns about opportunistic timing
  • Form 4 filed promptly and signed (reported transaction 09/02/2025; filing executed 09/03/2025), meeting disclosure requirements
Negative
  • None.

Insights

TL;DR: Insider sale via a pre-established 10b5-1 plan reduces holdings modestly and follows routine disclosure practices.

The Form 4 documents a routine, rule-compliant disposition by the company’s President & CEO under a Rule 10b5-1 trading plan adopted August 16, 2024. The sale of 1,500 shares at $134.54 is modest relative to typical CEO holdings and the remaining direct holding is reported as 70,714 shares. The filing is properly executed by an attorney-in-fact and provides the required explanatory remark that the sale was pursuant to the 10b5-1 plan, which helps limit concerns about opportunistic timing. There is no indication in this filing of acquisitions, option exercises, or other derivative transactions.

TL;DR: Transaction is informationally neutral; small-scale sale under a previously adopted plan, no new material disclosures for investors.

The reported disposition does not introduce new operational or financial information about Plexus Corp. The size of the sale (1,500 shares) and the retained position (70,714 shares) are explicitly stated, and the use of a 10b5-1 plan suggests the transaction timing is pre-determined. For investors, this is a standard insider disclosure that maintains transparency but is not material by itself.

Todd P. Kelsey, Presidente e CEO nonché membro del consiglio di amministrazione di Plexus Corp (PLXS), ha comunicato la vendita di azioni della società effettuata nell'ambito di un piano 10b5-1 preesistente. Il 02/09/2025 ha ceduto 1.500 azioni ordinarie di Plexus al prezzo di $134,54 per azione. Dopo la vendita segnalata, il sig. Kelsey possedeva direttamente 70.714 azioni. La comunicazione indica che le operazioni sono state effettuate in base a un piano disciplinato dalla Rule 10b5-1 adottato il 16 agosto 2024, e il Modulo 4 è stato firmato il 03/09/2025 da un procuratore.

Todd P. Kelsey, presidente y CEO y miembro del directorio de Plexus Corp (PLXS), informó la venta de acciones de la compañía realizada bajo un plan 10b5-1 preestablecido. El 02/09/2025 dispuso la venta de 1.500 acciones ordinarias de Plexus a $134,54 por acción. Tras la operación notificada, el Sr. Kelsey poseía directamente 70.714 acciones. La presentación indica que las transacciones se efectuaron conforme a un plan Rule 10b5-1 adoptado el 16 de agosto de 2024, y el Formulario 4 fue firmado el 03/09/2025 por un apoderado.

플렉서스(Plexus Corp, PLXS)의 회장이자 CEO 겸 이사인 Todd P. Kelsey는 사전에 설정된 10b5-1 플랜에 따라 회사 주식을 매도했다고 보고했습니다. 2025년 9월 2일에 그는 보통주 1,500주를 주당 $134.54에 처분했습니다. 보고된 매도 후 Kelsey 씨는 직접 70,714주를 보유하고 있었습니다. 제출서류에는 거래가 2024년 8월 16일 채택된 Rule 10b5-1 플랜에 따라 이루어졌으며, Form 4는 2025년 9월 3일에 대리인이 서명했다고 명시되어 있습니다.

Todd P. Kelsey, président-directeur général et administrateur de Plexus Corp (PLXS), a déclaré la vente d'actions de la société réalisée dans le cadre d'un plan 10b5-1 préétabli. Le 02/09/2025, il a cédé 1 500 actions ordinaires de Plexus au prix de 134,54 $ par action. Après la vente déclarée, M. Kelsey possédait directement 70 714 actions. Le dépôt indique que les opérations ont été effectuées en vertu d'un plan Rule 10b5-1 adopté le 16 août 2024, et que le formulaire 4 a été signé le 03/09/2025 par un mandataire.

Todd P. Kelsey, Präsident & CEO sowie Direktor von Plexus Corp (PLXS), meldete den Verkauf von Unternehmensaktien im Rahmen eines vorab festgelegten 10b5-1-Plans. Am 02.09.2025 veräußerte er 1.500 Stammaktien von Plexus zum Preis von $134,54 je Aktie. Nach dem gemeldeten Verkauf hielt Herr Kelsey direkt 70.714 Aktien. Die Meldung besagt, dass die Transaktionen gemäß einem am 16. August 2024 angenommenen Rule‑10b5‑1‑Plan erfolgten und das Formular 4 am 03.09.2025 von einem Bevollmächtigten unterzeichnet wurde.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kelsey Todd P.

(Last) (First) (Middle)
ONE PLEXUS WAY

(Street)
NEENAH WI 54956

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PLEXUS CORP [ PLXS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.01 par value 09/02/2025 S(1) 1,500 D $134.54 70,714 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares were sold pursuant to a Rule 10b5-1 plan adopted on August 16, 2024.
Remarks:
/s/ Todd P. Kelsey, by Kate A. Gitter, Attorney-in-Fact 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did PLXS insider Todd P. Kelsey sell?

He sold 1,500 shares of Plexus Corp common stock at $134.54 per share on 09/02/2025.

Was the sale by PLXS insider part of a trading plan?

Yes. The sale was made pursuant to a Rule 10b5-1 plan adopted on August 16, 2024.

How many PLXS shares does Todd P. Kelsey own after the sale?

70,714 shares beneficially owned following the reported transaction, held directly.

When was the Form 4 for the PLXS transaction signed?

09/03/2025, signed by Todd P. Kelsey via an attorney-in-fact, Kate A. Gitter.

Does the Form 4 report any option exercises or derivative transactions?

No. Table II for derivative securities shows no entries; only a non-derivative sale is reported.
Plexus Corp

NASDAQ:PLXS

PLXS Rankings

PLXS Latest News

PLXS Latest SEC Filings

PLXS Stock Data

3.72B
26.52M
1.7%
100.01%
2.42%
Electronic Components
Printed Circuit Boards
Link
United States
NEENAH